# § 522.1850   Polysulfated glycosaminoglycan.

(a) *Specifications.* (1) Each 1-milliliter (mL) ampule of solution contains 250 milligrams (mg) polysulfated glycosaminoglycan.


(2) Each mL of solution packaged in 5-mL ampules or 20-, 30-, or 50-mL vials contains 100 mg polysulfated glycosaminoglycan.


(b) *Sponsor.* See No. 010797 in § 510.600(c) of this chapter.


(c) *Special considerations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.


(d) *Conditions of use*—(1) *Horses*—(i) *Indications for use.* For the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.


(ii) *Amount*—(A) *Intra-articular use (carpal)*: 250 mg once a week for 5 weeks.


(B) *Intramuscular use (carpal and hock)*: 500 mg every 4 days for 28 days.


(iii) *Limitations.* Do not use in horses intended for human consumption.


(2) *Dogs*—(i) *Indications for use.* For control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.


(ii) *Amount.* 2 mg per pound of body weight by intramuscular injection twice weekly for up to 4 weeks (maximum of 8 injections).



---

[N] [72 FR 56896, Oct. 5, 2007, as amended at 74 FR 67816, Dec. 21, 2009] 






